China · Delayed Price · Currency is CNY BMC Medical Statistics
Total Valuation
BMC Medical has a market cap or net worth of CNY 6.02 billion. The enterprise value is 3.56 billion.
| Market Cap | 6.02B |
| Enterprise Value | 3.56B |
Important Dates
The last earnings date was Thursday, April 23, 2026.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | May 28, 2025 |
Share Statistics
BMC Medical has 88.87 million shares outstanding. The number of shares has decreased by -0.33% in one year.
| Current Share Class | 88.87M |
| Shares Outstanding | 88.87M |
| Shares Change (YoY) | -0.33% |
| Shares Change (QoQ) | +0.74% |
| Owned by Insiders (%) | 29.18% |
| Owned by Institutions (%) | 21.12% |
| Float | 41.13M |
Valuation Ratios
The trailing PE ratio is 31.37 and the forward PE ratio is 22.97.
| PE Ratio | 31.37 |
| Forward PE | 22.97 |
| PS Ratio | 5.00 |
| PB Ratio | 1.95 |
| P/TBV Ratio | 1.98 |
| P/FCF Ratio | 68.27 |
| P/OCF Ratio | 48.74 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.95, with an EV/FCF ratio of 40.32.
| EV / Earnings | 18.51 |
| EV / Sales | 2.96 |
| EV / EBITDA | 14.95 |
| EV / EBIT | 16.41 |
| EV / FCF | 40.32 |
Financial Position
The company has a current ratio of 10.81, with a Debt / Equity ratio of 0.02.
| Current Ratio | 10.81 |
| Quick Ratio | 10.01 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.21 |
| Debt / FCF | 0.56 |
| Interest Coverage | 43.64 |
Financial Efficiency
Return on equity (ROE) is 6.61% and return on invested capital (ROIC) is 32.57%.
| Return on Equity (ROE) | 6.61% |
| Return on Assets (ROA) | 4.01% |
| Return on Invested Capital (ROIC) | 32.57% |
| Return on Capital Employed (ROCE) | 6.99% |
| Weighted Average Cost of Capital (WACC) | 7.19% |
| Revenue Per Employee | 1.37M |
| Profits Per Employee | 219,349 |
| Employee Count | 876 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 5.28 |
Taxes
In the past 12 months, BMC Medical has paid 30.39 million in taxes.
| Income Tax | 30.39M |
| Effective Tax Rate | 13.29% |
Stock Price Statistics
The stock price has decreased by -15.21% in the last 52 weeks. The beta is 0.53, so BMC Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | -15.21% |
| 50-Day Moving Average | 70.59 |
| 200-Day Moving Average | 83.29 |
| Relative Strength Index (RSI) | 44.29 |
| Average Volume (20 Days) | 1,015,925 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BMC Medical had revenue of CNY 1.20 billion and earned 192.15 million in profits. Earnings per share was 2.16.
| Revenue | 1.20B |
| Gross Profit | 640.00M |
| Operating Income | 216.74M |
| Pretax Income | 228.61M |
| Net Income | 192.15M |
| EBITDA | 227.82M |
| EBIT | 216.74M |
| Earnings Per Share (EPS) | 2.16 |
Balance Sheet
The company has 2.53 billion in cash and 49.32 million in debt, with a net cash position of 2.48 billion or 27.89 per share.
| Cash & Cash Equivalents | 2.53B |
| Total Debt | 49.32M |
| Net Cash | 2.48B |
| Net Cash Per Share | 27.89 |
| Equity (Book Value) | 3.09B |
| Book Value Per Share | 34.43 |
| Working Capital | 2.72B |
Cash Flow
In the last 12 months, operating cash flow was 123.54 million and capital expenditures -35.35 million, giving a free cash flow of 88.19 million.
| Operating Cash Flow | 123.54M |
| Capital Expenditures | -35.35M |
| Depreciation & Amortization | 11.08M |
| Net Borrowing | -262.49M |
| Free Cash Flow | 88.19M |
| FCF Per Share | 0.99 |
Margins
Gross margin is 53.19%, with operating and profit margins of 18.01% and 15.97%.
| Gross Margin | 53.19% |
| Operating Margin | 18.01% |
| Pretax Margin | 19.00% |
| Profit Margin | 15.97% |
| EBITDA Margin | 18.93% |
| EBIT Margin | 18.01% |
| FCF Margin | 7.33% |
Dividends & Yields
This stock pays an annual dividend of 0.66, which amounts to a dividend yield of 0.99%.
| Dividend Per Share | 0.66 |
| Dividend Yield | 0.99% |
| Dividend Growth (YoY) | -60.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 21.32% |
| Buyback Yield | 0.33% |
| Shareholder Yield | 1.32% |
| Earnings Yield | 3.19% |
| FCF Yield | 1.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 29, 2024. It was a forward split with a ratio of 1.4.
| Last Split Date | May 29, 2024 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |